Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
43
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study

Kazuki Ide1 Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
,
Yohei Kawasaki1 Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, JapanCorrespondence[email protected]
,
Hiroshi Yamada1 Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
&
Naohiko Masaki2 The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan
Pages 1217-1223 | Published online: 22 Mar 2016

References

  • GhanyMGStraderDBThomasDLSeeffLBAmerican Association for the Study of Liver DiseasesDiagnosis, management, and treatment of hepatitis C: an updateHepatology2009491335137419330875
  • World Health Organization [webpage on the Internet]Hepatitis C Fact Sheet No. 164 July 20152015 Available from: http://www.who.int/mediacentre/factsheets/fs164/en/Accessed August 12, 2015
  • AverhoffFMGlassNHoltzmanDGlobal burden of hepatitis C: considerations for healthcare providers in the United StatesClin Infect Dis201255suppl 1S10S1522715208
  • GhanyMGNelsonDRStraderDBThomasDLSeeffLBAmerican Association for Study of Liver DiseasesAn update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesHepatology2011541433144421898493
  • GaneEJStedmanCAHylandRHNucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis CN Engl J Med2013368344423281974
  • LawitzEPoordadFFPangPSSofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trialLancet201438351552324209977
  • MizokamiMYokosukaOTakeharaTLedipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trialLancet Infect Dis20151564565325863559
  • PawlotskyJMNew hepatitis C therapies: the toolbox, strategies, and challengesGastroenterology20141461176119224631495
  • NegroFAlbertiAThe global health burden of hepatitis C virus infectionLiver Int201131suppl 21321651699
  • MasakiNYamagiwaYShimboTPrefectural Members Contributing to the Japanese Interferon DatabaseRegional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort studyBMC Public Health20151556626088426
  • Gonzalez-PeraltaRPKellyDAHaberBInternational Pediatric Hepatitis C Therapy GroupInterferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokineticsHepatology2005421010101816250032
  • HosmerDWJrLemeshowSSturdivantRXApplied Logistic Regression3rd edHoboken, NJJohn Wiley & Sons2013
  • LarsenKPetersenJHBudtz-JørgensenEEndahlLInterpreting parameters in the logistic regression model with random effectsBiometrics20005690991410985236
  • AkaikeHA new look at the statistical model identificationIEEE Trans Automat Contr197419716723
  • SchwarzGEstimating the dimension of a modelAnn Stat19786461464
  • Ministry of Health, Labor Welfare of Japan [webpage on the Internet]Health Policy Publication No. 0330-282012 Available from: http://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iryou/iryou_keikaku/dl/tsuuchi_iryou_keikaku.pdfAccessed August 12, 2015
  • O’ConnorGTQuintonHBTravenNDGeographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular ProjectJAMA199928162763310029124
  • SteyerbergEWEarleCCNevilleBAWeeksJCRacial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patientsJ Clin Oncol20052351051715659496
  • PfefferMAClaggettBAssmannSFRegional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialCirculation2015131344225406305
  • SpauldingACWeinbaumCMLauDTA framework for management of hepatitis C in prisonsAnn Intern Med200614476276916702592
  • JouJHSulkowskiMSNovielloSAnalysis of site performance in academic-based and community-based centers in the IDEAL StudyJ Clin Gastroenterol201347e91e9523787248
  • MassieBMClelandJGArmstrongPWRegional differences in the characteristics and treatment of patients participating in an international heart failure trialJ Card Fail19984389573498
  • CookNLHicksLSO’MalleyAJKeeganTGuadagnoliELandonBEAccess to specialty care and medical services in community health centersHealth Aff (Millwood)2007261459146817848458
  • AdashiEYGeigerHJFineMDHealth care reform and primary care – the growing importance of the community health centerN Engl J Med20103622047205020427777

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.